Loading clinical trials...
Loading clinical trials...
Tempus Priority Study: An Observational Study of Patients Who Have Received Comprehensive Genomic Profiling
Conditions
Interventions
Observation
Locations
2
United States
UT Southwestern
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Start Date
October 19, 2020
Primary Completion Date
October 19, 2026
Completion Date
October 19, 2030
Last Updated
May 6, 2025
NCT04541381
NCT05468034
NCT03137095
NCT06594926
NCT07177937
NCT06926283
Lead Sponsor
Tempus AI
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions